Invesco’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565M | Buy |
1,075,824
+225,078
| +26% | +$118M | 0.1% | 238 |
|
|
2025
Q1 | $540M | Sell |
850,746
-13,503
| -2% | -$8.56M | 0.1% | 233 |
|
|
2024
Q4 | $616M | Sell |
864,249
-296,924
| -26% | -$212M | 0.11% | 201 |
|
|
2024
Q3 | $1.22B | Buy |
1,161,173
+244,753
| +27% | +$257M | 0.24% | 68 |
|
|
2024
Q2 | $963M | Sell |
916,420
-69,648
| -7% | -$73.2M | 0.2% | 88 |
|
|
2024
Q1 | $949M | Buy |
986,068
+221,061
| +29% | +$213M | 0.2% | 87 |
|
|
2023
Q4 | $672M | Buy |
765,007
+21,659
| +3% | +$19M | 0.16% | 133 |
|
|
2023
Q3 | $612M | Sell |
743,348
-165,714
| -18% | -$136M | 0.16% | 134 |
|
|
2023
Q2 | $653M | Buy |
909,062
+24,307
| +3% | +$17.5M | 0.17% | 121 |
|
|
2023
Q1 | $727M | Buy |
884,755
+191,892
| +28% | +$158M | 0.2% | 98 |
|
|
2022
Q4 | $500M | Buy |
692,863
+51,541
| +8% | +$37.2M | 0.15% | 160 |
|
|
2022
Q3 | $442M | Buy |
641,322
+13,135
| +2% | +$9.05M | 0.14% | 170 |
|
|
2022
Q2 | $371M | Buy |
628,187
+25,256
| +4% | +$14.9M | 0.11% | 223 |
|
|
2022
Q1 | $421M | Buy |
602,931
+14,720
| +3% | +$10.3M | 0.11% | 239 |
|
|
2021
Q4 | $371M | Buy |
588,211
+103,773
| +21% | +$65.5M | 0.09% | 287 |
|
|
2021
Q3 | $293M | Buy |
484,438
+25,958
| +6% | +$15.7M | 0.07% | 345 |
|
|
2021
Q2 | $256M | Sell |
458,480
-10,864
| -2% | -$6.07M | 0.06% | 400 |
|
|
2021
Q1 | $222M | Buy |
469,344
+70,883
| +18% | +$33.5M | 0.06% | 416 |
|
|
2020
Q4 | $193M | Buy |
398,461
+108,214
| +37% | +$52.3M | 0.06% | 443 |
|
|
2020
Q3 | $162M | Buy |
290,247
+31,119
| +12% | +$17.4M | 0.05% | 432 |
|
|
2020
Q2 | $162M | Sell |
259,128
-43,407
| -14% | -$27.1M | 0.06% | 405 |
|
|
2020
Q1 | $148M | Sell |
302,535
-6,820
| -2% | -$3.33M | 0.06% | 371 |
|
|
2019
Q4 | $116M | Sell |
309,355
-1,002,899
| -76% | -$377M | 0.04% | 594 |
|
|
2019
Q3 | $364M | Sell |
1,312,254
-32,019
| -2% | -$8.88M | 0.1% | 235 |
|
|
2019
Q2 | $421M | Buy |
1,344,273
+46,055
| +4% | +$14.4M | 0.11% | 216 |
|
|
2019
Q1 | $533M | Buy |
1,298,218
+66,786
| +5% | +$27.4M | 0.18% | 123 |
|
|
2018
Q4 | $460M | Buy |
1,231,432
+19,546
| +2% | +$7.3M | 0.18% | 128 |
|
|
2018
Q3 | $490M | Buy |
1,211,886
+67,071
| +6% | +$27.1M | 0.15% | 148 |
|
|
2018
Q2 | $395M | Buy |
1,144,815
+108,565
| +10% | +$37.5M | 0.13% | 173 |
|
|
2018
Q1 | $357M | Buy |
1,036,250
+73,355
| +8% | +$25.3M | 0.13% | 175 |
|
|
2017
Q4 | $362M | Buy |
962,895
+65,519
| +7% | +$24.6M | 0.13% | 184 |
|
|
2017
Q3 | $401M | Sell |
897,376
-33,253
| -4% | -$14.9M | 0.15% | 165 |
|
|
2017
Q2 | $457M | Buy |
930,629
+244
| +0% | +$120K | 0.14% | 158 |
|
|
2017
Q1 | $361M | Buy |
930,385
+42,057
| +5% | +$16.3M | 0.12% | 190 |
|
|
2016
Q4 | $326M | Buy |
888,328
+41,562
| +5% | +$15.3M | 0.11% | 209 |
|
|
2016
Q3 | $340M | Buy |
846,766
+22,483
| +3% | +$9.04M | 0.12% | 200 |
|
|
2016
Q2 | $288M | Sell |
824,283
-179,634
| -18% | -$62.7M | 0.11% | 220 |
|
|
2016
Q1 | $362M | Sell |
1,003,917
-282,066
| -22% | -$102M | 0.15% | 159 |
|
|
2015
Q4 | $698M | Buy |
1,285,983
+234,111
| +22% | +$127M | 0.28% | 67 |
|
|
2015
Q3 | $489M | Buy |
1,051,872
+565
| +0.1% | +$263K | 0.21% | 100 |
|
|
2015
Q2 | $536M | Sell |
1,051,307
-19,322
| -2% | -$9.86M | 0.21% | 102 |
|
|
2015
Q1 | $483M | Sell |
1,070,629
-212,853
| -17% | -$96.1M | 0.19% | 115 |
|
|
2014
Q4 | $527M | Buy |
1,283,482
+134,855
| +12% | +$55.3M | 0.2% | 112 |
|
|
2014
Q3 | $414M | Buy |
1,148,627
+8,748
| +0.8% | +$3.15M | 0.17% | 135 |
|
|
2014
Q2 | $322M | Sell |
1,139,879
-184,552
| -14% | -$52.1M | 0.13% | 192 |
|
|
2014
Q1 | $398M | Buy |
1,324,431
+81,757
| +7% | +$24.5M | 0.16% | 139 |
|
|
2013
Q4 | $342M | Buy |
1,242,674
+18,862
| +2% | +$5.19M | 0.14% | 164 |
|
|
2013
Q3 | $383M | Buy |
1,223,812
+166,914
| +16% | +$52.2M | 0.17% | 124 |
|
|
2013
Q2 | $238M | Buy |
+1,056,898
| New | +$238M | 0.11% | 207 |
|